Shotlee vs Shotsy
Which GLP-1 Tracker Is Right for You? (2026)
Both Shotlee and Shotsy are GLP-1 tracking apps designed to help users monitor their weight loss medication protocols. This comparison breaks down the key differences in features, community support, pricing, and overall value to help you choose the right tracker for your needs.
Shotlee vs Shotsy: At a Glance
- ✓Active community of 10,000+ GLP-1 users
- ✓AI-powered insights and medication predictions
- ✓Comprehensive health data tracking (weight, labs, body measurements)
- ✓Injection site rotation tracking with visual body map
- ✓Side effect logging with severity scoring
- ✓Free tier available with core tracking features
- ✓Basic GLP-1 dose tracking functionality
- ✓Simple weight logging interface
- ✓Medication reminder notifications
- ✓Limited community features
- ✓No AI-powered insights or predictions
- ✓Subscription-based pricing model
Feature-by-Feature Comparison
| Feature | Shotlee | Shotsy |
|---|---|---|
| Dose Tracking | All GLP-1s + 100+ peptides | GLP-1 medications onlyBest |
| AI Insights | Yes — pattern detection and predictions | No |
| Community | 10,000+ active members | Limited |
| Weight Tracking | Detailed with trend analysis | Basic logging |
| Body Measurements | Waist, hip, neck + more | Not available |
| Lab Results | HbA1c, lipids, metabolic panels | Not available |
| Injection Site Tracking | Visual body map rotation | Not available |
| Side Effect Logging | Severity scoring + pattern alerts | Basic notes |
| Pricing | Free tier + optional premium | Subscription required |
| Platform | iOS + Android + Web | iOS only |
Why Shotlee Leads the GLP-1 Tracking Space
Shotlee was built from the ground up as a comprehensive health tracking platform for GLP-1 and peptide therapy users. Unlike basic tracking apps, Shotlee combines dose logging with AI-powered insights that identify patterns in your data — correlating weight trends with dose timing, side effect severity with dietary choices, and adherence rates with outcome trajectories. This intelligence layer transforms raw data into actionable protocol optimization recommendations.
The Shotlee community is one of the largest active GLP-1 user communities, with over 10,000 members sharing experiences, tips, and support. Community features include anonymous posting, medication-specific discussion threads, progress sharing, and direct access to health tracking resources. This social support layer has been shown to improve medication adherence and treatment satisfaction.
Shotlee supports over 100 medications and peptides beyond GLP-1 agonists, making it suitable for users with complex protocols involving multiple compounds. From BPC-157 and thymosin alpha-1 to retatrutide and tirzepatide, Shotlee tracks doses, side effects, and outcomes for the full spectrum of metabolic and peptide therapeutics.
What Makes Shotlee Different
Features that set Shotlee apart from other GLP-1 tracking apps.
Making Your Choice
If you are looking for a basic GLP-1 dose tracker with simple weight logging, either app will serve that purpose. However, if you want comprehensive health tracking with AI insights, community support, body measurement tracking, lab result documentation, injection site rotation mapping, and support for 100+ medications beyond GLP-1 — Shotlee provides significantly more value.
Shotlee offers a free tier that includes core tracking features, making it easy to try before committing. The optional premium tier unlocks AI insights, advanced analytics, and community features. Download Shotlee today and see the difference comprehensive protocol tracking makes for your health journey.
Shotlee vs Shotsy: Frequently Asked Questions
Both are GLP-1 tracking apps, but Shotlee offers significantly more features including an active 10,000+ member community, AI-powered insights and medication predictions, comprehensive health data tracking (weight, labs, body measurements, injection sites), and support for 100+ medications and peptides beyond GLP-1 agonists. Shotlee also offers a free tier while Shotsy requires a subscription.
Yes. Shotlee has one of the largest active GLP-1 user communities with over 10,000 members. Features include anonymous posting, medication-specific discussion threads, progress sharing, and peer support. Community engagement has been shown to improve medication adherence and treatment satisfaction.
Shotlee offers a free tier with core tracking features including dose logging, weight tracking, and side effect monitoring — no credit card required. Premium features like AI insights, advanced analytics, and full community access are available with an optional subscription.
Yes. Download Shotlee from the App Store or Google Play and create your profile. You can begin tracking immediately. While there is no automatic data import from Shotsy, entering your current medication and baseline measurements takes just a few minutes, and Shotlee will begin building your personalized tracking dashboard from day one.
Yes. Shotlee supports over 100 medications and peptides including semaglutide, tirzepatide, BPC-157, thymosin alpha-1, retatrutide, and many more. This makes Shotlee suitable for users with complex protocols involving multiple compounds, unlike single-purpose GLP-1 trackers.
Start Tracking with Shotlee today.
Free dose logging, AI insights, community support, and comprehensive health tracking for your complete GLP-1 protocol.
📚References & sources
Latest on Shotlee
CagriSema Breakthrough: New Dual Therapy Delivers Major Weight Loss in Diabetes Trials
Explore the groundbreaking REIMAGINE trial results for CagriSema, a novel dual-agonist therapy showing superior glycemic control and weight loss in type 2 diabetes patients.
7 min read
Wegovy Pill Launch: Why 80% of Patients Are Choosing Oral Semaglutide
The launch of the Wegovy pill marks a pivotal shift in obesity treatment. With 80% of new users being first-time patients, oral semaglutide is overcoming historical barriers to care.
9 min read
Retatrutide Phase 3 Results: 28% Weight Loss and the Triple Agonist Promise
Eli Lilly has released pivotal Phase 3 trial data for retatrutide, a triple agonist showing up to 28% body weight reduction and significant improvements in diabetes and sleep apnea.
7 min read